Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

5,000 patients join landmark kidney disease registry

NCT ID NCT06117852

First seen Sep 30, 2025 · Last updated Jun 22, 2026 · Updated 36 times

Summary

This study is creating a registry of 5,000 adults with chronic kidney disease (CKD) to track their health over time. Researchers will collect information on diagnosis, treatment, and outcomes like kidney function decline, heart problems, and death. The goal is to understand current care patterns, find risk factors for disease worsening, and build a model to predict progression. No new treatments are being tested—this is purely an observation and data-gathering effort.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Research Site

    Baotou, China

  • Research Site

    Beijing, China

  • Research Site

    Changsha, China

  • Research Site

    Changzhou, China

  • Research Site

    Chengdu, China

  • Research Site

    Chongqing, China

  • Research Site

    Dongguan, China

  • Research Site

    Guangzhou, China

  • Research Site

    Haikou, China

  • Research Site

    Hefei, China

  • Research Site

    Hengyang, China

  • Research Site

    Huaian, China

  • Research Site

    Jilin City, China

  • Research Site

    Jining, China

  • Research Site

    Nanchang, China

  • Research Site

    Nanjing, China

  • Research Site

    Nanning, China

  • Research Site

    Ningbo, China

  • Research Site

    Panjin, China

  • Research Site

    Pingxiang, China

  • Research Site

    Shanghai, China

  • Research Site

    Shantou, China

  • Research Site

    Shenzhen, China

  • Research Site

    Taizhou, China

  • Research Site

    Wenzhou, China

  • Research Site

    Wuhan, China

  • Research Site

    Wuxi, China

  • Research Site

    Xiamen, China

  • Research Site

    Xianyang, China

  • Research Site

    Yantai, China

  • Research Site

    Yibin, China

  • Research Site

    Zhongshan, China

  • Research Site

    Zhuzhou, China

  • Research Site

    Zigong, China

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this registry could help doctors better predict how CKD progresses and identify gaps in current treatment guidelines.

What could go wrong

This is an observational study, not a treatment trial. It collects data but does not test any new drug or intervention, so it cannot directly improve patient outcomes.

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.